TY - JOUR
T1 - Organically Modified Silica Nanoparticles Interaction with Macrophage Cells
T2 - Assessment of Cell Viability on the Basis of Physicochemical Properties
AU - Kumar, Dhiraj
AU - Mutreja, Isha
AU - Keshvan, Prashant C.
AU - Bhat, Madhusudan
AU - Dinda, Amit K.
AU - Mitra, Susmita
N1 - Publisher Copyright:
© 2015 Wiley Periodicals, Inc.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Silica nanoparticles have drawn a lot of attention for nanomedicine application, and this is attributed to their biocompatibility and ease of surface functionalization. However, successful utilization of these inorganic systems for biomedical application depends on their physicochemical properties. This study, therefore, discusses in vitro toxicity of organically modified silica nanoparticles on the basis of size, shape, and surface properties of silica nanoparticles. Spherical- and oval-shaped nanoparticles having hydroxyl and amine groups were synthesized in Tween 80 micelles using different organosilanes. Nanoparticles of similar size and morphology were considered for comparative assessment. "As-prepared" nanoparticles were characterized in terms of size, shape, and surface properties using ZetaSizer, transmission electron microscopy, and Fourier transform infrared to establish the above parameters. In vitro analysis in terms of nanoparticle-based toxicity was performed on J-774 (macrophage) cell line using propidium iodide-4′,6-diamidino-2-phenylindol and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. Fluorescent dye-entrapped nanoparticles were used to visualize the uptake of the nanoparticles by macrophage cells. Results from cell studies suggested low levels of toxicity for different nanoparticle formulations studied, therefore are suitable for nanocarrier application for poorly soluble molecules. On the contrary, the nanoparticles of similar size and shape, having amine groups and low net negative charge, do not exhibit any in vitro cytotoxicity.
AB - Silica nanoparticles have drawn a lot of attention for nanomedicine application, and this is attributed to their biocompatibility and ease of surface functionalization. However, successful utilization of these inorganic systems for biomedical application depends on their physicochemical properties. This study, therefore, discusses in vitro toxicity of organically modified silica nanoparticles on the basis of size, shape, and surface properties of silica nanoparticles. Spherical- and oval-shaped nanoparticles having hydroxyl and amine groups were synthesized in Tween 80 micelles using different organosilanes. Nanoparticles of similar size and morphology were considered for comparative assessment. "As-prepared" nanoparticles were characterized in terms of size, shape, and surface properties using ZetaSizer, transmission electron microscopy, and Fourier transform infrared to establish the above parameters. In vitro analysis in terms of nanoparticle-based toxicity was performed on J-774 (macrophage) cell line using propidium iodide-4′,6-diamidino-2-phenylindol and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. Fluorescent dye-entrapped nanoparticles were used to visualize the uptake of the nanoparticles by macrophage cells. Results from cell studies suggested low levels of toxicity for different nanoparticle formulations studied, therefore are suitable for nanocarrier application for poorly soluble molecules. On the contrary, the nanoparticles of similar size and shape, having amine groups and low net negative charge, do not exhibit any in vitro cytotoxicity.
KW - Drug Delivery Systems
KW - J-774 cell line
KW - ORMOSIL
KW - core-shell nanoparticles
KW - fluorescent nanoparticles
KW - micro-emulsion
KW - microencapsulation
KW - nano-toxicity
KW - nanoparticle
KW - organosilanes
KW - physico-chemical properties
KW - silica
UR - http://www.scopus.com/inward/record.url?scp=84944168658&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944168658&partnerID=8YFLogxK
U2 - 10.1002/jps.24614
DO - 10.1002/jps.24614
M3 - Article
C2 - 26295279
AN - SCOPUS:84944168658
SN - 0022-3549
VL - 104
SP - 3943
EP - 3951
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
IS - 11
ER -